PAR 3.70% 28.0¢ paradigm biopharmaceuticals limited..

As Mozz so eloquently and enthusiastically shares with us, the...

  1. 43 Posts.
    lightbulb Created with Sketch. 23
    As Mozz so eloquently and enthusiastically shares with us, the science and efficacy of ipps is without question imo. The simple fact is the extraordinary sums of money required to achieve approval is mind boggling, and together with PAR managements inability to estimate with any remote degree of accuracy what these costs might be, well who would touch us at this stage….until we have more certainty around process and cost we will remain where we are…just need to keep ticking those interim boxes and hang in there for now. Hopefully/surely the science will eventually win out (though a very small part of me has always worried fda may be under a little pressure from those opioid producing companies…but that couldnt happen in the states could it?)…
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.0¢
Change
0.010(3.70%)
Mkt cap ! $94.44M
Open High Low Value Volume
27.0¢ 29.0¢ 27.0¢ $102.7K 366.7K

Buyers (Bids)

No. Vol. Price($)
4 45537 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 3784 5
View Market Depth
Last trade - 11.34am 14/05/2024 (20 minute delay) ?
Last
28.0¢
  Change
0.010 ( 3.70 %)
Open High Low Volume
27.5¢ 29.0¢ 27.5¢ 21320
Last updated 11.34am 14/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.